EMILY FUNG: Open Payments
NPI 1720051329 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 7 payments from 4 companies in 2025. Trend: 2023 $109 · 2024 $91 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $75 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| BioMarin Pharmaceutical Inc. | 1 | $26 |
Products named: MOUNJARO, BEXSERO, GARDASIL 9, TRELEGY ELLIPTA, VOXZOGO 1.2mg, JARDIANCE.
Industry payments across CA — which companies pay providers there.
